Joseph P. Hagan, Chief Executive Officer at Regulus Therapeutics Inc. (RGLS), bought 100,000 shares at $1.09 ($109K) on 2025-01-30, disclosed to the SEC on 2025-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.09 | 50,000 | $55K | 50.0% |
| 2 | $1.09 | 50,000 | $55K | 50.0% |
| Total | $1.09 avg | 100,000 | $109K | 100% |
| Filing → |
| AUPH | SELL | 2023-05-23 | $3K | — | Filing → |
| RGLS | BUY | 2022-01-26 | $22K | — | Filing → |
| AUPH | SELL | 2022-01-04 | $1.8M | — | Filing → |